SCIENTIFIC & MEDICAL ACCOUNTABILITY STANDARDS WORKING GROUP
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To The
CALIFORNIA STEM CELL RESEARCH AND CURES ACT

Date: January 30-31, 2006

Time:  1/30/06 (9 AM – 5 PM) | 1/31/06 (8:30 AM – 1 PM)

Location:

PUBLIC SESSION

1. Welcome
2. Call to Order
3. Roll Call.

CONSENT ITEMS

4. Approval of Meeting Minutes from October 24, 2005
5. Approval of Meeting Minutes from December 1, 2005

REGULAR ITEMS

6. CIRM Staff Progress ReportIncluding but not limited to:
   1. Summary of Standards Working Group Outreach and Public Comment
   2. Rulemaking Process Review
   3. Assessing the Medical Risks of Human Oocyte Donation Conference
   4. IP Task Force Progress Report
   5. CIRM Grants Administration Policy Progress Report
7. Review of Draft CIRM Regulations language
   1. Study Group Notes: Oversight Standards for non-CIRM funded cell lines
   2. Section 100001: Definitions
   3. Sections 100002: Activities Not Eligible for CIRM Funding
   4. Section 100006: SCRO Review & Notification
   5. Section 100007: Ethically Derived Materials
   6. Section 100008: Informed Consent Requirements
   7. Section 100010: Materials Sharing
   8. Section 100009: Fairness and Diversity in Research (Proposed)
   9. The Standards Working Group encourages public participation and comment. Public comment will be invited after the review of each section of the draft CIRM regulations by the Working Group members.
8. Consideration of the Draft CIRM Regulations for Submission to the Independent Citizens’ Oversight Committee.
9. Adjournment

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizen’s Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at (415) 396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Scientific and Medical Research Funding Working Group meeting may be referred to Pat Beaupre Becker at the California Institute for Regenerative Medicine at pbecker@cirm.ca.gov or (415) 396-9105.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.